Literature DB >> 17329825

Crystallization and preliminary X-ray crystallographic analysis of enoyl-ACP reductase III (FabL) from Bacillus subtilis.

Kook-Han Kim1, Joon Kyu Park, Byung Hak Ha, Jin Ho Moon, Eunice EunKyeong Kim.   

Abstract

Enoyl-[acyl-carrier protein] reductase (enoyl-ACP reductase; ENR) is a key enzyme in type II fatty-acid synthase that catalyzes the last step in each elongation cycle. It has been considered as an antibiotic target since it is an essential enzyme in bacteria. However, recent studies indicate that some pathogens have more than one ENR. Bacillus subtilis is reported to have two ENRs, namely BsFabI and BsFabL. While BsFabI is similar to other FabIs, BsFabL shows very little sequence similarity and is NADPH-dependent instead of NADH-dependent as in the case of FabI. In order to understand these differences on a structural basis, BsFabL has been cloned, expressed and and crystallized. The crystal belongs to space group P622, with unit-cell parameters a = b = 139.56, c = 62.75 A, alpha = beta = 90, gamma = 120 degrees and one molecule of FabL in the asymmetric unit. Data were collected using synchrotron radiation (beamline 4A at the Pohang Light Source, Korea). The crystal diffracted to 2.5 A resolution.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17329825      PMCID: PMC2330183          DOI: 10.1107/S1744309107008469

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  23 in total

1.  A triclosan-resistant bacterial enzyme.

Authors:  R J Heath; C O Rock
Journal:  Nature       Date:  2000-07-13       Impact factor: 49.962

2.  Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery.

Authors:  J W Campbell; J E Cronan
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

Review 3.  The potential of bacterial fatty acid biosynthetic enzymes as a source of novel antibacterial agents.

Authors:  David J Payne
Journal:  Drug News Perspect       Date:  2004-04

4.  Crystallographic analysis of triclosan bound to enoyl reductase.

Authors:  A Roujeinikova; C W Levy; S Rowsell; S Sedelnikova; P J Baker; C A Minshull; A Mistry; J G Colls; R Camble; A R Stuitje; A R Slabas; J B Rafferty; R A Pauptit; R Viner; D W Rice
Journal:  J Mol Biol       Date:  1999-11-26       Impact factor: 5.469

5.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

Review 6.  Fatty acid synthesis and its regulation.

Authors:  S J Wakil; J K Stoops; V C Joshi
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

7.  Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene.

Authors:  R J Heath; J Li; G E Roland; C O Rock
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

8.  Discovery of a novel and potent class of FabI-directed antibacterial agents.

Authors:  David J Payne; William H Miller; Valerie Berry; John Brosky; Walter J Burgess; Emile Chen; Walter E DeWolf; Andrew P Fosberry; Rebecca Greenwood; Martha S Head; Dirk A Heerding; Cheryl A Janson; Deborah D Jaworski; Paul M Keller; Peter J Manley; Terrance D Moore; Kenneth A Newlander; Stewart Pearson; Brian J Polizzi; Xiayang Qiu; Stephen F Rittenhouse; Courtney Slater-Radosti; Kevin L Salyers; Mark A Seefeld; Martin G Smyth; Dennis T Takata; Irene N Uzinskas; Kalindi Vaidya; Nicola G Wallis; Scott B Winram; Catherine C K Yuan; William F Huffman
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

9.  Identification and characterization of inhibitors of bacterial enoyl-acyl carrier protein reductase.

Authors:  Losee L Ling; Jun Xian; Syed Ali; Bolin Geng; Jun Fan; Debra M Mills; Anthony C Arvanites; Hernan Orgueira; Mark A Ashwell; Gilles Carmel; Yibin Xiang; Donald T Moir
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

10.  Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure-reactivity analysis of FabI inhibition by triclosan analogues.

Authors:  Sharada Sivaraman; Todd J Sullivan; Francis Johnson; Polina Novichenok; Guanglei Cui; Carlos Simmerling; Peter J Tonge
Journal:  J Med Chem       Date:  2004-01-29       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.